Lumen Bio is a biotechnology startup that is revolutionizing the development and distribution of biologic drugs. Biologic drugs are products that are produced from living organisms or contain components of living organisms. These drugs have immense potential in treating various diseases but have been limited by the lack of scalable technology. Lumen Bio is addressing this gap by leveraging its patented technology to develop these drugs faster, at a lower cost, and with less risk than traditional methods.

The company operates in the biopharmaceutical market, serving a broad range of clients including hospitals, healthcare providers, and patients suffering from diseases such as Inflammatory Bowel Disease (IBD) and metabolic diseases. These are conditions that have been largely neglected by the healthcare industry due to the high costs associated with their treatment.

Lumen Bio's business model is centered around the development and commercialization of biologic drugs. The company makes money by selling these drugs to healthcare providers and hospitals. By reducing the cost and time of development, Lumen Bio is able to offer these drugs at a more affordable price, thereby increasing access for patients who need them.

In addition, Lumen Bio is also addressing other health issues such as gastrointestinal symptoms, which affect a significant number of patients, and diseases that are a leading cause of death worldwide. The company is also developing therapies for mild-to-moderate Crohn's disease and is working to protect travelers and US servicemembers from health risks.

Keywords: Biotechnology, Biologic Drugs, Patented Technology, Healthcare Providers, Hospitals, Inflammatory Bowel Disease, Metabolic Diseases, Drug Development, Affordable Treatment, Scalable Technology.